\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ unremarkable\\.\\ thyroid\\ normal\\.\\ lungs\\ clear\\.\\ cardiac\\ exam\\ wnl\\.\\ no\\ abdominal\\ masses\\.\\ \\ lan\\:\\ 24\\ hr\\ vma\\ 107\\.6\\ \\(0\\-10\\.0\\)\\,\\ epinephrine\\ 170\\ \\(\\.\\ 5\\-20\\)\\,\\ norepinephrine\\ 460\\ \\(15\\-18\\)\\ \\ total\\ catecholamines\\ 3196\\ \\(123\\-671\\ supine\\)\ \(0\)\
\-\ prazosin\\ 1mg\\ po\\ bid\\ prior\\ to\\ surgery\\ followed\\ by\\ surgical\\ excision\\.\\ \\ follow\\ up\\ with\\ repeat\\ vma\\ and\\ metanephrines\\ and\\ imaging\\ studies\\.\\ \\ if\\ the\\ pheochromocytoma\\ is\\ malignant\\,\\ as\\ evidenced\\ by\\ invasion\\ and\\ metastasis\\ then\\ treatment\\ is\\ primarily\\ surgical\\ with\\ chemotherapy\\ playing\\ only\\ a\\ palliative\\ role\\.\ \(0\)\
\-\ ct\\ chest\\ abd\\ pelvis\\ with\\ oral\\ and\\ iv\\ contrast\\ large\\ soft\\ tissue\\ mass\\ arising\\ from\\ left\\ adrenal\\ gland\\ measuring\\ 9\\.5\\ x\\ 8\\.9\\ x\\ 13cm\\ in\\ the\\ oblique\\ coronal\\,\\ ap\\,\\ and\\ craniocaudal\\ dimensions\\.\\ \\ loss\\ of\\ tissue\\ plane\\ between\\ tail\\ of\\ pancreas\\,\\ spleen\\,\\ and\\ bowel\\.\ \(0\)\
\-\ pheochromocytoma\ \(23\)\
\-\ hyperthyroidism\\,\\ meduloblastoma\\,\\ soft\\ tissue\\ sarcoma\\,\\ incidentaloma\\,\\ myeloolipoma\\,\\ renal\\ cell\\ carcinoma\\,\\ adrenal\\ cortical\\ carcinoma\ \(0\)\
\-\ 30\\ y\\/o\\ male\\ with\\ no\\ significant\\ pmh\\ presents\\ with\\ symptoms\\ of\\ headache\\ and\\ flushing\\.\\ \\ was\\ discovered\\ to\\ have\\ bp\\ 250\\/140\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vma\\:\\ 0\\.07552428983589723\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.05935141460174376\ \(0\)\
\-\ 0\\-10\\.0\\:\\ 0\\.047395260343905905\ \(0\)\
\-\ 3196\\:\\ 0\\.047395260343905905\ \(0\)\
\-\ 123\\-671\\:\\ 0\\.047395260343905905\ \(0\)\
\-\ myeloolipoma\\:\\ 0\\.047395260343905905\ \(0\)\
\-\ adrenal\\:\\ 0\\.046525613486390956\ \(0\)\
\-\ 107\\.6\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ 15\\-18\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ catecholamines\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ prazosin\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ 13cm\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ incidentaloma\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ 250\\/140\\:\\ 0\\.04366866259895997\ \(0\)\
\-\ 460\\:\\ 0\\.04148874266289456\ \(0\)\
\-\ 1mg\\:\\ 0\\.04148874266289456\ \(0\)\
\-\ meduloblastoma\\:\\ 0\\.04148874266289456\ \(0\)\
\-\ lan\\:\\ 0\\.039942064854014026\ \(0\)\
\-\ 5\\-20\\:\\ 0\\.039942064854014026\ \(0\)\
\-\ metanephrines\\:\\ 0\\.039942064854014026\ \(0\)\
\-\ flushing\\:\\ 0\\.039942064854014026\ \(0\)\
\-\ epinephrine\\:\\ 0\\.038742368341572034\ \(0\)\
\-\ norepinephrine\\:\\ 0\\.038742368341572034\ \(0\)\
\-\ 8\\.9\\:\\ 0\\.038742368341572034\ \(0\)\
\-\ 170\\:\\ 0\\.036933377822103146\ \(0\)\
\-\ 9\\.5\\:\\ 0\\.03501577059662609\ \(0\)\
\-\ bid\\:\\ 0\\.03360521003497291\ \(0\)\
\-\ tissue\\:\\ 0\\.032668083684719254\ \(0\)\
\-\ evidenced\\:\\ 0\\.03128917285168015\ \(0\)\
\-\ dimensions\\:\\ 0\\.03128917285168015\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.03077675253015152\ \(0\)\
\-\ x\\:\\ 0\\.030312541240295456\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.02967570730087188\ \(0\)\
\-\ palliative\\:\\ 0\\.02798172317915201\ \(0\)\
\-\ role\\:\\ 0\\.027173754345553417\ \(0\)\
\-\ po\\:\\ 0\\.026256412856140714\ \(0\)\
\-\ carcinoma\\:\\ 0\\.0260422330109233\ \(0\)\
\-\ supine\\:\\ 0\\.025658425570601873\ \(0\)\
\-\ plane\\:\\ 0\\.025658425570601873\ \(0\)\
\-\ tail\\:\\ 0\\.02529378795587735\ \(0\)\
\-\ spleen\\:\\ 0\\.02470973504726017\ \(0\)\
\-\ playing\\:\\ 0\\.024477626596371954\ \(0\)\
\-\ abd\\:\\ 0\\.024328274101172623\ \(0\)\
\-\ primarily\\:\\ 0\\.02411174776172133\ \(0\)\
\-\ wnl\\:\\ 0\\.023573664651199915\ \(0\)\
\-\ pancreas\\:\\ 0\\.023510038534818183\ \(0\)\
\-\ pmh\\:\\ 0\\.02285575393816485\ \(0\)\
\-\ discovered\\:\\ 0\\.022636280849346272\ \(0\)\
\-\ soft\\:\\ 0\\.022375556602081185\ \(0\)\
\-\ hr\\:\\ 0\\.022373968138757933\ \(0\)\
\-\ invasion\\:\\ 0\\.022123860527817646\ \(0\)\
\-\ repeat\\:\\ 0\\.021611440206289016\ \(0\)\
\-\ oblique\\:\\ 0\\.021351243750042513\ \(0\)\
\-\ sarcoma\\:\\ 0\\.020456360913280874\ \(0\)\
\-\ exam\\:\\ 0\\.0201853111822531\ \(0\)\
\-\ bp\\:\\ 0\\.019943940591752248\ \(0\)\
\-\ total\\:\\ 0\\.01978344078987224\ \(0\)\
\-\ gland\\:\\ 0\\.019566498340820804\ \(0\)\
\-\ oral\\:\\ 0\\.019357971324502756\ \(0\)\
\-\ surgical\\:\\ 0\\.019314212583348964\ \(0\)\
\-\ coronal\\:\\ 0\\.019129156193218907\ \(0\)\
\-\ arising\\:\\ 0\\.019018299810408503\ \(0\)\
\-\ \\,\\:\\ 0\\.018920595977014707\ \(0\)\
\-\ excision\\:\\ 0\\.018856186701963942\ \(0\)\
\-\ thyroid\\:\\ 0\\.01882963680067049\ \(0\)\
\-\ measuring\\:\\ 0\\.018372880228219063\ \(0\)\
\-\ 24\\:\\ 0\\.017862671938849193\ \(0\)\
\-\ 30\\:\\ 0\\.017667146970188577\ \(0\)\
\-\ cardiac\\:\\ 0\\.017499122542747155\ \(0\)\
\-\ lungs\\:\\ 0\\.017396712892367074\ \(0\)\
\-\ metastasis\\:\\ 0\\.017197566270429714\ \(0\)\
\-\ studies\\:\\ 0\\.017158607084834195\ \(0\)\
\-\ clear\\:\\ 0\\.016986702221218525\ \(0\)\
\-\ ap\\:\\ 0\\.016801929944314183\ \(0\)\
\-\ iv\\:\\ 0\\.016765725470220934\ \(0\)\
\-\ cortical\\:\\ 0\\.01674771425040759\ \(0\)\
\-\ pelvis\\:\\ 0\\.0166940398203851\ \(0\)\
\-\ malignant\\:\\ 0\\.0166057563246199\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01646745045774659\ \(0\)\
\-\ then\\:\\ 0\\.016349284292591883\ \(0\)\
\-\ headache\\:\\ 0\\.01577949159981612\ \(0\)\
\-\ \\(\\:\\ 0\\.015534660779437862\ \(0\)\
\-\ masses\\:\\ 0\\.015530066655892943\ \(0\)\
\-\ followed\\:\\ 0\\.015402558448272966\ \(0\)\
\-\ \\)\\:\\ 0\\.015344896604587207\ \(0\)\
\-\ by\\:\\ 0\\.01529968713166532\ \(0\)\
\-\ unremarkable\\:\\ 0\\.015210034509043338\ \(0\)\
\-\ follow\\:\\ 0\\.014597846623367926\ \(0\)\
\-\ between\\:\\ 0\\.01456180395819486\ \(0\)\
\-\ bowel\\:\\ 0\\.014408352327337417\ \(0\)\
\-\ only\\:\\ 0\\.013814041174650193\ \(0\)\
\-\ renal\\:\\ 0\\.013803631986333706\ \(0\)\
\-\ loss\\:\\ 0\\.013335828884238923\ \(0\)\
\-\ y\\/o\\:\\ 0\\.012723811988277638\ \(0\)\
\-\ if\\:\\ 0\\.012466362547207718\ \(0\)\
\-\ cell\\:\\ 0\\.012409896298825196\ \(0\)\
\-\ up\\:\\ 0\\.012354016941151739\ \(0\)\
\-\ significant\\:\\ 0\\.012354016941151739\ \(0\)\
\-\ prior\\:\\ 0\\.011796305226894429\ \(0\)\
\-\ abdominal\\:\\ 0\\.011483436764097394\ \(0\)\
\-\ symptoms\\:\\ 0\\.011449771381172792\ \(0\)\
\-\ physical\\:\\ 0\\.011271533707426014\ \(0\)\
\-\ surgery\\:\\ 0\\.011155908948173521\ \(0\)\
\-\ chest\\:\\ 0\\.010993166666975907\ \(0\)\
\-\ imaging\\:\\ 0\\.010763837765890337\ \(0\)\
\-\ contrast\\:\\ 0\\.010283740251655406\ \(0\)\
\-\ large\\:\\ 0\\.010045927052855268\ \(0\)\
\-\ have\\:\\ 0\\.009948591819167161\ \(0\)\
\-\ presents\\:\\ 0\\.009385184384451215\ \(0\)\
\-\ treatment\\:\\ 0\\.009299015911832726\ \(0\)\
\-\ no\\:\\ 0\\.009252087641976365\ \(0\)\
\-\ male\\:\\ 0\\.008307556655308997\ \(0\)\
\-\ normal\\:\\ 0\\.00720221749784463\ \(0\)\
\-\ as\\:\\ 0\\.006949341429538322\ \(0\)\
\-\ from\\:\\ 0\\.006808794156743078\ \(0\)\
\-\ and\\:\\ 0\\.006774532473793168\ \(0\)\
\-\ ct\\:\\ 0\\.00642636372791421\ \(0\)\
\-\ mass\\:\\ 0\\.006389575306169702\ \(0\)\
\-\ \\:\\:\\ 0\\.006076746322530457\ \(0\)\
\-\ is\\:\\ 0\\.006046137401986298\ \(0\)\
\-\ was\\:\\ 0\\.005313320011901542\ \(0\)\
\-\ left\\:\\ 0\\.005140350910069434\ \(0\)\
\-\ to\\:\\ 0\\.00459213019831168\ \(0\)\
\-\ with\\:\\ 0\\.0031452735508034875\ \(0\)\
\-\ \\.\\:\\ 0\\.0024811503723951695\ \(0\)\
\-\ in\\:\\ 0\\.002265576506130403\ \(0\)\
\-\ a\\:\\ 0\\.0021322569990247383\ \(0\)\
\-\ of\\:\\ 0\\.001879093561257878\ \(0\)\
\-\ the\\:\\ 0\\.001486551448426084\ \(0\)\
